Addressing upstream bottlenecks, Xiamen Winbio Biotechnology is bolstering supply-chain self-reliance with domestically produced antigen and antibody raw materials.


In vitro diagnostic raw materials are the “chips” of the industry, and achieving independent control over upstream supplies is pivotal for sector development. Established in 2017, Xiamen Winbio Biotechnology Co., Ltd. is headquartered in the Haicang Biomedical Industrial Park. As a national-level high-tech enterprise and a specialized, refined, distinctive, and innovative company in Xiamen, it focuses on the R&D and production of active raw materials such as antigens, antibodies, and recombinant proteins.

In vitro diagnostic raw materials are the “chips” of the industry, and achieving independent control over upstream supplies is pivotal for sector development. Established in 2017, Xiamen Winbio Biotechnology Co., Ltd. is headquartered in the Haicang Biomedical Industrial Park. As a national-level high-tech enterprise and a specialized, refined, distinctive, and innovative company in Xiamen, it focuses on the R&D and production of active raw materials such as antigens, antibodies, and recombinant proteins.

The company’s business spans recombinant protein engineering, antigen and antibody production, and platform‑based raw material applications, with products compatible across the four major assay technologies: chemiluminescence, ELISA, fluorescence, and colloidal gold. Backed by an expert team with over 30 years of industry experience, Winbio Biotech has a deep understanding of the performance nuances of each platform’s raw materials, offering downstream reagent manufacturers both standardized supplies and tailored development solutions.

In response to industry supply-chain demands, Winbio Biotech continuously optimizes its manufacturing processes, rigorously ensures batch-to-batch consistency, and builds a reliable domestic supply of IVD raw materials. This supports Chinese diagnostic companies in breaking free from upstream raw-material constraints and drives the high-quality, self-reliant development of the in vitro diagnostics sector.

Leave a Message Online


Please provide the correct information, and we will contact you promptly!